glp-1 agonists with cardiovascular benefit The Biology of Glucagon-like Peptide-1 GLP-1 receptor agonists and cardiovascular

42% of adults under age 65 with private insurance could be eligible for GLP-1 drugs for weight loss, per KFF analysis in September 2024 But the two approved GLP-1s for weight loss, Wegovy and Zepbound, cost around $1,000 per month without discounts

30 Furthermore, a comparative trial of exenatide and liraglutide in T2DM subjects concluded that both incretin mimetics were associated with a significant reduction in body weight when compared to baseline (2.87 kg and 3.24 kg, respectively)

To manage constipation, focus on two essential elements: fiber and hydration, says Ana Pruteanu, M.S., RDN, CEDS-C, LDN

Young: Particularly after, like, a drug treatment, is gonna be fat instead of muscle mass because, obviously, right, like, maybe with physical exercise, youre still maintaining those good behaviors a little bit more with exercising more regularly, or same with eating patternsmaybe youre still kind of, like, eating a little bit better than you were before, even if you fully stop a diet or, like, an intensive training regimen for exercise

This positioning is crucial, as it frames GLP-1 RAs not as first-line treatments but as important tools in a comprehensive management strategy

Will there be side effects